Cargando…
FRI124 Insights From The Incidence Of Primary Aldosteronism In Patients With Hypokalemia (IPAHK(+)) - Study
Disclosure: S. Gruber: None. E. Stasi: None. A. Boan Pion: None. R. Steiner: None. I. Sudano: None. F. Beuschlein: None. Background: Hypokalemia plays an important role in the diagnosis and management of primary aldosteronism (PA). The hypokalemic variant of the disease accounts for about one third...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553477/ http://dx.doi.org/10.1210/jendso/bvad114.637 |
_version_ | 1785116179898040320 |
---|---|
author | Gruber, Sven Stasi, Evangelia Boan Pion, Antonio Steiner, Regula Sudano, Isabella Beuschlein, Felix |
author_facet | Gruber, Sven Stasi, Evangelia Boan Pion, Antonio Steiner, Regula Sudano, Isabella Beuschlein, Felix |
author_sort | Gruber, Sven |
collection | PubMed |
description | Disclosure: S. Gruber: None. E. Stasi: None. A. Boan Pion: None. R. Steiner: None. I. Sudano: None. F. Beuschlein: None. Background: Hypokalemia plays an important role in the diagnosis and management of primary aldosteronism (PA). The hypokalemic variant of the disease accounts for about one third of all cases. However, little is known about the incidence of PA in a hypokalemic population. Design: The IPAHK(+) study is an epidemiological, monocentric, cross-sectional trial to provide evidence on the incidence of PA in a hypokalemic outpatient population. Methods: Recruitment of outpatients with hypokalemia ≤3 mmol/l is carried out on a continuous referral-basis through an automated data delivery system at the University Hospital Zurich (USZ). Todate, 69 patients underwent the study protocol, which includes guideline-compliant workup for PA. Results: The mean age of the participants was 52.5±1.5 years with a sex ratio of 35:34 women to men, a mean potassium value of 2.77±0.03 mmol/l [1.8; 3.0] and a prevalence of arterial hypertension of71%. PA was diagnosed in 45.9% of all participants, all of whom had a history of hypertension. The incidence of PA increased continuously with decreasing potassium level with proportions of 26.7%,45.8% and 59.1% in the subgroups of 3.0 mmol/l (n=15), 2.8-2.9 (n=24) and ≤2.7 mmol/l (n=22),respectively. In the subgroup of hypertensives the incidence of PA was as high as 65.1%. Prior testing,60.9% of all patients presented at least with one plausible other cause for their hypokalemia with potential drug triggers accounting for the largest portion (33.3%). Among participants on diuretics the incidence of PA was 57.9%. Conclusions: The incidence of PA in the investigated outpatient population was more than 4 out of 10and inversely correlated with baseline potassium levels. Moderate or severe hypokalemia, regardless of its cause, should therefore prompt evaluation for PA in hypertensive individuals. Normotensive PA was not observed in our cohort. The significance of the study is limited by the still low number of enrolled patients with a potential selection bias. Presentation: Friday, June 16, 2023 |
format | Online Article Text |
id | pubmed-10553477 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-105534772023-10-06 FRI124 Insights From The Incidence Of Primary Aldosteronism In Patients With Hypokalemia (IPAHK(+)) - Study Gruber, Sven Stasi, Evangelia Boan Pion, Antonio Steiner, Regula Sudano, Isabella Beuschlein, Felix J Endocr Soc Cardiovascular Endocrinology Disclosure: S. Gruber: None. E. Stasi: None. A. Boan Pion: None. R. Steiner: None. I. Sudano: None. F. Beuschlein: None. Background: Hypokalemia plays an important role in the diagnosis and management of primary aldosteronism (PA). The hypokalemic variant of the disease accounts for about one third of all cases. However, little is known about the incidence of PA in a hypokalemic population. Design: The IPAHK(+) study is an epidemiological, monocentric, cross-sectional trial to provide evidence on the incidence of PA in a hypokalemic outpatient population. Methods: Recruitment of outpatients with hypokalemia ≤3 mmol/l is carried out on a continuous referral-basis through an automated data delivery system at the University Hospital Zurich (USZ). Todate, 69 patients underwent the study protocol, which includes guideline-compliant workup for PA. Results: The mean age of the participants was 52.5±1.5 years with a sex ratio of 35:34 women to men, a mean potassium value of 2.77±0.03 mmol/l [1.8; 3.0] and a prevalence of arterial hypertension of71%. PA was diagnosed in 45.9% of all participants, all of whom had a history of hypertension. The incidence of PA increased continuously with decreasing potassium level with proportions of 26.7%,45.8% and 59.1% in the subgroups of 3.0 mmol/l (n=15), 2.8-2.9 (n=24) and ≤2.7 mmol/l (n=22),respectively. In the subgroup of hypertensives the incidence of PA was as high as 65.1%. Prior testing,60.9% of all patients presented at least with one plausible other cause for their hypokalemia with potential drug triggers accounting for the largest portion (33.3%). Among participants on diuretics the incidence of PA was 57.9%. Conclusions: The incidence of PA in the investigated outpatient population was more than 4 out of 10and inversely correlated with baseline potassium levels. Moderate or severe hypokalemia, regardless of its cause, should therefore prompt evaluation for PA in hypertensive individuals. Normotensive PA was not observed in our cohort. The significance of the study is limited by the still low number of enrolled patients with a potential selection bias. Presentation: Friday, June 16, 2023 Oxford University Press 2023-10-05 /pmc/articles/PMC10553477/ http://dx.doi.org/10.1210/jendso/bvad114.637 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Cardiovascular Endocrinology Gruber, Sven Stasi, Evangelia Boan Pion, Antonio Steiner, Regula Sudano, Isabella Beuschlein, Felix FRI124 Insights From The Incidence Of Primary Aldosteronism In Patients With Hypokalemia (IPAHK(+)) - Study |
title | FRI124 Insights From The Incidence Of Primary Aldosteronism In Patients With Hypokalemia (IPAHK(+)) - Study |
title_full | FRI124 Insights From The Incidence Of Primary Aldosteronism In Patients With Hypokalemia (IPAHK(+)) - Study |
title_fullStr | FRI124 Insights From The Incidence Of Primary Aldosteronism In Patients With Hypokalemia (IPAHK(+)) - Study |
title_full_unstemmed | FRI124 Insights From The Incidence Of Primary Aldosteronism In Patients With Hypokalemia (IPAHK(+)) - Study |
title_short | FRI124 Insights From The Incidence Of Primary Aldosteronism In Patients With Hypokalemia (IPAHK(+)) - Study |
title_sort | fri124 insights from the incidence of primary aldosteronism in patients with hypokalemia (ipahk(+)) - study |
topic | Cardiovascular Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553477/ http://dx.doi.org/10.1210/jendso/bvad114.637 |
work_keys_str_mv | AT grubersven fri124insightsfromtheincidenceofprimaryaldosteronisminpatientswithhypokalemiaipahkstudy AT stasievangelia fri124insightsfromtheincidenceofprimaryaldosteronisminpatientswithhypokalemiaipahkstudy AT boanpionantonio fri124insightsfromtheincidenceofprimaryaldosteronisminpatientswithhypokalemiaipahkstudy AT steinerregula fri124insightsfromtheincidenceofprimaryaldosteronisminpatientswithhypokalemiaipahkstudy AT sudanoisabella fri124insightsfromtheincidenceofprimaryaldosteronisminpatientswithhypokalemiaipahkstudy AT beuschleinfelix fri124insightsfromtheincidenceofprimaryaldosteronisminpatientswithhypokalemiaipahkstudy |